Company Filing History:
Years Active: 2012-2015
Title: Innovations by Tom Boone in Atherosclerosis Treatment
Introduction
Tom Boone is an accomplished inventor based in Newbury Park, CA (US). He has made significant contributions to the field of medical science, particularly in the treatment of cardiovascular diseases. With a total of 3 patents, Boone's work focuses on innovative solutions to combat atherosclerosis and related conditions.
Latest Patents
One of Tom Boone's latest patents involves modified lecithin-cholesterol acyltransferase (LCAT) enzymes. This invention provides compounds, pharmaceutical compositions, and methods for treating atherosclerosis, coronary heart disease, and thrombosis. The goal is to decrease or prevent the accumulation of cholesterol in a subject by modifying the LCAT polypeptide. This innovative approach has the potential to significantly impact the treatment landscape for cardiovascular diseases.
Career Highlights
Tom Boone is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to further his research and development efforts in the field of cardiovascular health. Boone's dedication to innovation is evident in his ongoing projects and contributions to medical science.
Collaborations
Some of Tom Boone's notable coworkers include Mingyue Zhou and Wenyan Shen. Their collaborative efforts have enhanced the research and development initiatives at Amgen, fostering an environment of innovation and discovery.
Conclusion
Tom Boone's contributions to the field of medical science, particularly through his patents on modified LCAT enzymes, showcase his commitment to improving health outcomes. His work at Amgen and collaborations with fellow researchers highlight the importance of teamwork in driving innovation.